Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy-Accessing Participants: Incidence, Clinical Course, and Outcomes

Naidoo, K., Moodley, M. C., Hassan-Moosa, R., Dookie, N., Yende-Zuma, N., Perumal, R., Dawood, H., Mvelase, N. R., Mathema, B., & Karim, S. A. (2022). Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes. Clinical Infectious Diseases, 75(9), 1628–1636. https://doi.org/10.1093/cid/ciac185
Authors:
Kogieleum Naidoo
Mikaila C Moodley
Razia Hassan-Moosa
Navisha Dookie
Nonhlanhla Yende-Zuma
Rubeshan Perumal
Halima Dawood
Nomonde R. Mvelase
Barun Mathema
Salim Abdool Karim
Affiliated Authors:
Barun Mathema
Salim Abdool Karim
Columbia Affiliation:
Subjects:
Acquired Immunodeficiency Syndrome (MeSH)
HIV Infections (MeSH)
Tuberculosis (MeSH)
Author Keywords:
hiv
clinical tb
incidence
prevalence
subclinical tb
elink
Publication Type:
Article
Unique ID:
10.1093/cid/ciac185
PMID:
35247054
DOI:
10.1093/cid/ciac185
Journal:
Clinical Infectious Diseases
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record

Record Created: